Covestor’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
Covestor's KRYS Position: Q3 2026 in Review
Covestor reduced its Krystal Biotech (KRYS) stake by 69% in Q3 2026, selling an estimated $117K and leaving 155 shares worth $52K. The position accounts for 0.03% of the portfolio, ranked #716.
Covestor first reported a position in KRYS in Q4 2021 and has held it in 20 quarters since. The position peaked at $314K in Q3 2025. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.
- Covestor held 155 shares of Krystal Biotech worth $52K as of Q3 2026.
- Covestor sold 338 Krystal Biotech shares in Q3 2026, an estimated $117K.
- Krystal Biotech made up 0.03% of Covestor's portfolio in Q3 2026, its #716 holding.
- Covestor first reported a position in Krystal Biotech in Q4 2021 and has held it in 20 quarters since.
- Covestor's Krystal Biotech position peaked at $314K in Q3 2025.
- 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.